← Back to headlines
Eli Lilly's Retatrutide Poised to Extend Lead in Weight Loss Market
Eli Lilly and Co.'s drug Retatrutide is being evaluated for its potential to further solidify the company's dominant position in the weight loss medication market.
16 Jun, 18:58 — 16 Jun, 18:58
Sources
Showing 1 of 1 sources
